CO6400201A2 - Suministro liberado sostenido de uno o más agentes - Google Patents
Suministro liberado sostenido de uno o más agentesInfo
- Publication number
- CO6400201A2 CO6400201A2 CO11096469A CO11096469A CO6400201A2 CO 6400201 A2 CO6400201 A2 CO 6400201A2 CO 11096469 A CO11096469 A CO 11096469A CO 11096469 A CO11096469 A CO 11096469A CO 6400201 A2 CO6400201 A2 CO 6400201A2
- Authority
- CO
- Colombia
- Prior art keywords
- agent
- glaucoma
- treatment
- core
- latanoprost
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00772—Apparatus for restoration of tear ducts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
Abstract
Los sistemas de implantes lagrimales de entrega y los métodos descritos en este documento proporcionan una liberación controlada de un agente terapéutico para el tratamiento de enfermedades, incluyendo tratamiento de glaucoma, hipertensión ocular o presión intraocular elevada, con latanoprost u otros agentes anti-glaucoma. También se suministra el tratamiento de la enfermedad, incluyendo glaucoma, hipertensión ocular o presión intraocular elevada, con latanoprost u otros agentes anti-glaucoma en conjunto con intensificador de la penetración, tal como cloruro de benzalconio, y/o lágrimas artificiales. También se proporcionan implantes que contienen un núcleo de drogas emplacable en un punto lagrimal junto a un ojo de un paciente para la liberación controlada de un agente terapéutico, tal corno latanoprost para el tratamiento del glaucoma, una droga principal que contiene un polímero tal como silicona reticulada, un agente terapéutico y un excipiente, en donde el excipiente puede aumentar la tasa de liberación del agente del núcleo de drogas, o puede aumentar la carga de fármaco en el núcleo, sin pérdida de homogeneidad deseable del agente dentro del núcleo, o se puede mejorar la retención del agente en el ojo o en el fluido lagrimal, o puede aumentar la penetración en la córnea del agente en el ojo.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14686009P | 2009-01-23 | 2009-01-23 | |
US15290909P | 2009-02-16 | 2009-02-16 | |
US22889409P | 2009-07-27 | 2009-07-27 | |
US27700009P | 2009-09-18 | 2009-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6400201A2 true CO6400201A2 (es) | 2012-03-15 |
Family
ID=42356409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11096469A CO6400201A2 (es) | 2009-01-23 | 2011-08-01 | Suministro liberado sostenido de uno o más agentes |
Country Status (16)
Country | Link |
---|---|
US (3) | US20100209477A1 (es) |
EP (1) | EP2389221B1 (es) |
JP (2) | JP5885244B2 (es) |
KR (1) | KR20110129869A (es) |
CN (2) | CN102341144B (es) |
AU (1) | AU2010206610A1 (es) |
BR (1) | BRPI1007318A2 (es) |
CA (1) | CA2750381C (es) |
CO (1) | CO6400201A2 (es) |
HK (1) | HK1162151A1 (es) |
IL (1) | IL214199A0 (es) |
MX (1) | MX2011007804A (es) |
RU (1) | RU2011134043A (es) |
SG (1) | SG173069A1 (es) |
WO (1) | WO2010085696A2 (es) |
ZA (1) | ZA201105345B (es) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7922702B2 (en) | 2004-07-02 | 2011-04-12 | Qlt Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
US8795711B2 (en) | 2006-03-31 | 2014-08-05 | Mati Therapeutics Inc. | Drug delivery methods, structures, and compositions for nasolacrimal system |
KR20100050566A (ko) * | 2007-09-07 | 2010-05-13 | 큐엘티 플러그 딜리버리, 인코포레이티드 | 눈물 임플랜트 및 이에 관련된 방법 |
EP2205193A2 (en) | 2007-09-07 | 2010-07-14 | QLT Plug Delivery, Inc. | Lacrimal implant detection |
JP2011520805A (ja) * | 2008-05-09 | 2011-07-21 | キューエルティー プラグ デリバリー,インク. | 緑内障および高眼圧症治療のための活性剤の持続送達 |
MX2011008875A (es) * | 2009-02-23 | 2011-09-26 | Quadra Logic Tech Inc | Implantes lagrimales y metodos relacionados. |
TWI495459B (zh) * | 2009-03-31 | 2015-08-11 | Johnson & Johnson Vision Care | 淚管塞(二) |
US9421127B2 (en) | 2009-03-31 | 2016-08-23 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
CN102596097B (zh) | 2009-06-03 | 2015-05-20 | 弗赛特实验室有限责任公司 | 一种眼插入件 |
US20110105986A1 (en) * | 2009-09-21 | 2011-05-05 | Ben Bronstein | Uveoscleral drainage device |
US9259351B2 (en) | 2010-03-29 | 2016-02-16 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
US9259352B2 (en) | 2010-03-29 | 2016-02-16 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
US10272040B2 (en) | 2010-08-12 | 2019-04-30 | Nanyang Technological University | Liposomal formulation for ocular drug delivery |
US8591484B2 (en) | 2010-09-15 | 2013-11-26 | AlphaMed, Inc. | Lacrimal punctum measurement and occlusion |
US8783451B2 (en) * | 2011-02-18 | 2014-07-22 | Allergan, Inc. | Unit dose breakable vial with integrated brush applicator |
US20120276186A1 (en) | 2011-04-29 | 2012-11-01 | Ghebremeskel Alazar N | Sustained release latanoprost implant |
CN103889401B (zh) * | 2011-08-29 | 2017-10-13 | Qlt公司 | 持续释放递送活性剂以治疗青光眼和高眼压 |
US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
CN103917202B (zh) | 2011-09-14 | 2016-06-29 | 弗赛特影像5股份有限公司 | 眼插入件装置和方法 |
US8834406B2 (en) * | 2011-10-21 | 2014-09-16 | Snyder Biomedical Corporation | Biocompatible glaucoma drainage device |
JP2014534864A (ja) | 2011-10-28 | 2014-12-25 | プレサージュ バイオサイエンシズ,インコーポレイテッド | 薬物デリバリー方法 |
US20130220346A1 (en) * | 2012-02-28 | 2013-08-29 | Victor Lust | Balloon punctal plug |
CN105473130A (zh) * | 2012-05-03 | 2016-04-06 | 麦提疗法有限公司 | 治疗开角型青光眼和高眼压症的药物递送系统和方法 |
US9827250B2 (en) * | 2012-07-31 | 2017-11-28 | Johnson & Johnson Vision Care, Inc. | Lens incorporating myopia control optics and muscarinic agents |
CN103767822A (zh) * | 2012-10-24 | 2014-05-07 | 鸿富锦精密工业(深圳)有限公司 | 辅助装置及利用该辅助装置进行眼药水投药的方法 |
EP2911623B1 (en) | 2012-10-26 | 2019-08-14 | Forsight Vision5, Inc. | Ophthalmic system for sustained release of drug to eye |
WO2014113384A2 (en) * | 2013-01-15 | 2014-07-24 | The Regents Of The University Of Colorado, A Body Corporate | Lacrimal system drug delivery device |
MY177958A (en) * | 2013-10-31 | 2020-09-28 | Allergan Inc | Prostamide-containing intraocular implants and methods of use thereof |
US9956195B2 (en) | 2014-01-07 | 2018-05-01 | Nanyang Technological University | Stable liposomal formulations for ocular drug delivery |
US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
WO2017007819A1 (en) * | 2015-07-06 | 2017-01-12 | The Regents Of The University Of Colorado, A Body Corporate | Lacrimal drainage system diagnostic implant |
WO2017015471A1 (en) * | 2015-07-21 | 2017-01-26 | Avedro, Inc. | Systems and methods for treaments of an eye with a photosensitizer |
US11857461B2 (en) | 2015-11-23 | 2024-01-02 | The Regents Of The University Of Colorado, A Body Corporate | Lacrimal system for drug delivery |
RU2613435C1 (ru) * | 2015-12-17 | 2017-03-16 | Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Дренаж для хирургического лечения глаукомы |
WO2017201255A1 (en) | 2016-05-20 | 2017-11-23 | The Regents Of The University Of Colorado, A Body Corporate | Lacrimal drug delivery device |
EP3474794A4 (en) * | 2016-07-13 | 2019-07-24 | Mati Therapeutics Inc. | STATIC PIN INTRODUCTION TOOL FOR LACRYMAL IMPLANT |
US10603274B2 (en) * | 2016-09-30 | 2020-03-31 | Mati Therapeutics Inc. | Ophthalmic drug sustained release formulation and uses thereof |
EP4046609A1 (en) * | 2016-09-30 | 2022-08-24 | Mati Therapeutics Inc. | Ophthalmic drug sustained release formulation and uses thereof |
CN106963543A (zh) * | 2017-02-16 | 2017-07-21 | 武汉奥绿新生物科技股份有限公司 | 引流型柔性微型支架及医疗器械 |
US11806493B2 (en) * | 2018-02-02 | 2023-11-07 | Tusker Medical, Inc. | Systems, apparatus, and methods for transport and delivery of therapeutic substance to middle ear |
WO2019222121A1 (en) * | 2018-05-12 | 2019-11-21 | Goldenbiotech, Llc | Self-retaining implantable drug delivery device |
MX2020014160A (es) * | 2018-06-25 | 2021-03-09 | Titan Pharmaceuticals Inc | Implantes para liberacion de sustancias farmaceuticas lipofilicas o anfifilicas. |
US20220183880A1 (en) * | 2019-04-02 | 2022-06-16 | The Regents Of The University Of California | Method and apparatus to modify the cornea using electrochemistry |
TWI819268B (zh) | 2020-01-16 | 2023-10-21 | 詹姆斯 W 希爾 | 藉由基因轉導改變眼睛顏色 |
WO2021188985A2 (en) * | 2020-03-19 | 2021-09-23 | The Government Of The United States Of America, As Represented By The Secretary Of The Navy | Concentric permeation system for transfer of neutral gaseous material |
US20210338481A1 (en) * | 2020-04-20 | 2021-11-04 | Bruce B. Becker | Lacrimal gland implant for drug delivery and method |
EP4210598A1 (en) * | 2020-09-10 | 2023-07-19 | Oasis Medical, Inc. | Devices and methods for occluding the punctal opening |
DE102021202061A1 (de) * | 2021-03-03 | 2022-09-08 | B. Braun Melsungen Aktiengesellschaft | Medizinprodukt, Funktionsteil für ein Medizinprodukt und Verfahren zum Sterilisieren und/oder zum Herstellen von Sterilisationsbeständigkeit eines Medizinprodukts oder Funktionsteils |
JP2024517970A (ja) * | 2021-05-14 | 2024-04-23 | グラウコス コーポレイション | 涙点プラグの材料及び方法 |
WO2024097437A1 (en) * | 2022-11-03 | 2024-05-10 | Becker Bruce B | Anchored lacrimal caruncle implant for drug delivery and method |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281654A (en) * | 1980-04-07 | 1981-08-04 | Alza Corporation | Drug delivery system for controlled ocular therapy |
ES2078175B1 (es) * | 1993-12-31 | 1996-10-16 | Cusi Lab | Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones. |
US6196993B1 (en) * | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
US6566345B2 (en) * | 2000-04-28 | 2003-05-20 | Fziomed, Inc. | Polyacid/polyalkylene oxide foams and gels and methods for their delivery |
US6534693B2 (en) | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
FR2834446B1 (fr) * | 2002-01-08 | 2004-02-13 | Ioltechnologie Production | Clou meatique a expansion |
WO2003062412A1 (fr) * | 2002-01-18 | 2003-07-31 | Takara Bio Inc. | Fucane sulfate |
US20040043067A1 (en) * | 2002-06-19 | 2004-03-04 | Salamone Joseph C. | Fluorosiloxane matrix controlled diffusion drug delivery systems |
FR2844182B1 (fr) * | 2002-09-11 | 2004-12-03 | Humanoptics Ag | Bouchon d'obturation d'un canalicule lacrymal |
US7785578B2 (en) * | 2002-10-11 | 2010-08-31 | Aciont, Inc. | Non-invasive ocular drug delivery |
WO2004075781A2 (en) | 2003-02-26 | 2004-09-10 | Medivas, Llc | Bioactive stents and methods for use thereof |
US7662864B2 (en) * | 2003-06-04 | 2010-02-16 | Rutgers, The State University Of New Jersey | Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
US20050129731A1 (en) * | 2003-11-03 | 2005-06-16 | Roland Horres | Biocompatible, biostable coating of medical surfaces |
US20050232972A1 (en) * | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
US7799336B2 (en) * | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
WO2006002366A2 (en) * | 2004-06-24 | 2006-01-05 | Surmodics, Inc. | Biodegradable ocular devices, methods and systems |
DE602005024026D1 (de) | 2004-08-27 | 2010-11-18 | Yokohama Rubber Co Ltd | Notlaufstützkörper für luftreifen |
US8795711B2 (en) * | 2006-03-31 | 2014-08-05 | Mati Therapeutics Inc. | Drug delivery methods, structures, and compositions for nasolacrimal system |
US9173773B2 (en) * | 2006-06-21 | 2015-11-03 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
CN101505694B (zh) * | 2006-06-21 | 2012-02-22 | 庄臣及庄臣视力保护公司 | 用于递送活性试剂的泪点塞 |
CN101505695A (zh) * | 2006-06-21 | 2009-08-12 | 庄臣及庄臣视力保护公司 | 用于递送活性试剂的泪点塞 |
AU2007339929A1 (en) * | 2006-12-26 | 2008-07-10 | Qlt Inc. | Drug delivery implants for inhibition of optical defects |
UY30883A1 (es) * | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
US20080299176A1 (en) * | 2007-05-30 | 2008-12-04 | Yu-Chin Lai | Drug delivery device comprising crosslinked polyurethane-siloxane-containing copolymers |
CN101327356A (zh) * | 2007-06-21 | 2008-12-24 | 庄臣及庄臣视力保护公司 | 用于输送活性剂的泪点塞 |
CN101327357A (zh) * | 2007-06-21 | 2008-12-24 | 庄臣及庄臣视力保护公司 | 用于输送活性剂的泪点塞 |
CN104856782B (zh) * | 2007-09-07 | 2017-09-12 | 马缇医疗股份有限公司 | 泪腺植入物及相关方法 |
WO2009035567A2 (en) * | 2007-09-07 | 2009-03-19 | Qlt Plug Delivery, Inc | Insertion and extraction tools for lacrimal implants |
DK2207529T3 (en) | 2007-09-07 | 2015-03-09 | Mati Therapeutics Inc | PHARMACEUTICAL cores for the sustained release of therapeutic agents |
EP2205193A2 (en) * | 2007-09-07 | 2010-07-14 | QLT Plug Delivery, Inc. | Lacrimal implant detection |
KR20100050566A (ko) * | 2007-09-07 | 2010-05-13 | 큐엘티 플러그 딜리버리, 인코포레이티드 | 눈물 임플랜트 및 이에 관련된 방법 |
CN104825270B (zh) * | 2008-02-18 | 2017-10-24 | 马缇医疗股份有限公司 | 泪管植入物及相关方法 |
CN104623741A (zh) * | 2008-04-30 | 2015-05-20 | 马缇医疗股份有限公司 | 复合泪管植入物及相关方法 |
EP2328527A1 (en) * | 2008-07-08 | 2011-06-08 | QLT Plug Delivery, Inc. | Lacrimal implant body including comforting agent |
WO2010071844A1 (en) * | 2008-12-19 | 2010-06-24 | Qlt Plug Delivery, Inc | Substance delivering punctum implants and methods |
MX2011008875A (es) * | 2009-02-23 | 2011-09-26 | Quadra Logic Tech Inc | Implantes lagrimales y metodos relacionados. |
-
2010
- 2010-01-22 JP JP2011548154A patent/JP5885244B2/ja active Active
- 2010-01-22 CN CN201080009993.9A patent/CN102341144B/zh active Active
- 2010-01-22 SG SG2011052487A patent/SG173069A1/en unknown
- 2010-01-22 US US12/692,452 patent/US20100209477A1/en not_active Abandoned
- 2010-01-22 CA CA2750381A patent/CA2750381C/en active Active
- 2010-01-22 CN CN201410551110.7A patent/CN104306103B/zh active Active
- 2010-01-22 KR KR1020117019322A patent/KR20110129869A/ko not_active Application Discontinuation
- 2010-01-22 MX MX2011007804A patent/MX2011007804A/es unknown
- 2010-01-22 AU AU2010206610A patent/AU2010206610A1/en not_active Abandoned
- 2010-01-22 BR BRPI1007318-3A patent/BRPI1007318A2/pt not_active IP Right Cessation
- 2010-01-22 EP EP10733939.2A patent/EP2389221B1/en active Active
- 2010-01-22 RU RU2011134043/14A patent/RU2011134043A/ru not_active Application Discontinuation
- 2010-01-22 WO PCT/US2010/021868 patent/WO2010085696A2/en active Application Filing
-
2011
- 2011-07-20 ZA ZA2011/05345A patent/ZA201105345B/en unknown
- 2011-07-20 IL IL214199A patent/IL214199A0/en active IP Right Grant
- 2011-08-01 CO CO11096469A patent/CO6400201A2/es not_active Application Discontinuation
-
2012
- 2012-03-14 HK HK12102579.1A patent/HK1162151A1/xx unknown
-
2014
- 2014-08-25 US US14/468,262 patent/US20150064230A1/en not_active Abandoned
-
2015
- 2015-01-17 US US14/599,463 patent/US20150133546A1/en not_active Abandoned
-
2016
- 2016-02-04 JP JP2016019437A patent/JP2016127945A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2010085696A9 (en) | 2011-06-03 |
EP2389221C0 (en) | 2023-08-16 |
US20150064230A1 (en) | 2015-03-05 |
WO2010085696A3 (en) | 2010-11-04 |
HK1162151A1 (en) | 2012-08-24 |
AU2010206610A1 (en) | 2011-08-11 |
JP2016127945A (ja) | 2016-07-14 |
US20150133546A1 (en) | 2015-05-14 |
EP2389221A2 (en) | 2011-11-30 |
RU2011134043A (ru) | 2013-02-20 |
EP2389221B1 (en) | 2023-08-16 |
JP5885244B2 (ja) | 2016-03-15 |
CN102341144A (zh) | 2012-02-01 |
BRPI1007318A2 (pt) | 2019-04-09 |
CA2750381A1 (en) | 2010-07-29 |
ZA201105345B (en) | 2012-03-28 |
US20100209477A1 (en) | 2010-08-19 |
CN102341144B (zh) | 2014-10-29 |
EP2389221A4 (en) | 2017-11-01 |
CN104306103A (zh) | 2015-01-28 |
KR20110129869A (ko) | 2011-12-02 |
WO2010085696A2 (en) | 2010-07-29 |
SG173069A1 (en) | 2011-08-29 |
CN104306103B (zh) | 2017-04-19 |
MX2011007804A (es) | 2011-12-06 |
CA2750381C (en) | 2021-03-16 |
IL214199A0 (en) | 2011-08-31 |
JP2012515628A (ja) | 2012-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6400201A2 (es) | Suministro liberado sostenido de uno o más agentes | |
CO6351718A2 (es) | Suministro de liberacion sostenida de agentes activos para tratar glaucoma e hipertension ocular | |
CA3010374A1 (en) | Intraocular pressure reduction with intracameral bimatoprost implants | |
Kamburoglu et al. | Intacs implantation with sequential collagen cross-linking treatment in postoperative LASIK ectasia | |
JP4685311B2 (ja) | 眼薬送出装置 | |
AR056254A1 (es) | SISTEMAS DE ADMINISTRACION INTRAOCULAR DE UNA DROGA DE LIBERACION SOSTENIDA QUE CONTIENE RETINOIDES, UN POLíMERO BIODEGRADABLE Y LOS METODOS RELACIONADOS | |
WO2013030679A3 (en) | Sustained release delivery of active agents to treat glaucoma and ocular hypertension | |
TW200603775A (en) | Anti-excitotoxic sustained release intraocular implants and related methods | |
BR112012025581A2 (pt) | implantes de reservatório de liberação sustentada para distribuição de fármaco intracameral | |
AR042917A1 (es) | Dispositivo de liberacion sostenida para la administracion ocular de agentes adrenergicos y uso de agentes adrenergicos para su preparacion | |
IL194515A (en) | Implants for epic-tear drainage system for drug therapy | |
JP2011519301A5 (es) | ||
WO2011091205A3 (en) | Intracameral sustained release therapeutic agent implants | |
WO2011094758A2 (en) | Methods and devices for crosslinking of corneal collagen and for treatment of disorders of the eye | |
EP2437684A4 (en) | PREVIOUS SEGMENT MEDICATION DISTRIBUTION | |
CN108578059A (zh) | 一种可控药物缓释的角膜接触镜 | |
Zhu et al. | Transplantation of amniotic membrane for choroidal hole to treat suprachoroidal silicone oil migration. | |
JP2014530904A (ja) | 円錐角膜の治療に有効であり、イオントフォレシスにより導入される改良された架橋結合組成物 | |
Crnej et al. | A novel murine model for keratoprosthesis | |
IN2014DN09713A (es) | ||
Ho | Human adult umbilical stem cells: potential treatment for atrophic AMD | |
Meier-Gibbons et al. | Aqueous Humor Dynamics and Its Influence on Glaucoma | |
CN107280852A (zh) | 一种一体式泪液流出延迟器及与其配套的安放装置 | |
Chung et al. | Diplopia and periorbital mass associated with Miragel buckling explant | |
Agarwal | Topical anaesthesia for cataract surgery: Patient’s and surgeon’s perspective |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |